Detailed text transcripts for TV channel - CNN - 20170319:23:32:00
Ask about once-a-day namzaric. namzaric is approved for moderate to severe alzheimer's disease in patients who are taking donepezil. it may improve cognition and overall function, and may slow the worsening of symptoms for a while. namzaric does not change the underlying disease progression. don't take if allergic to memantine, donepezil, piperidine, or any of the ingredients in namzaric. tell the doctor about any conditions; including heart, lung, bladder, kidney or liver problems, seizures, stomach ulcers, or procedures with anesthesia. serious side effects may occur, including muscle proble...